全文获取类型
收费全文 | 222655篇 |
免费 | 4727篇 |
国内免费 | 118篇 |
专业分类
耳鼻咽喉 | 1515篇 |
儿科学 | 8764篇 |
妇产科学 | 4423篇 |
基础医学 | 22744篇 |
口腔科学 | 2027篇 |
临床医学 | 18866篇 |
内科学 | 39647篇 |
皮肤病学 | 1428篇 |
神经病学 | 21037篇 |
特种医学 | 9901篇 |
外国民族医学 | 38篇 |
外科学 | 33412篇 |
综合类 | 2850篇 |
一般理论 | 99篇 |
预防医学 | 24840篇 |
眼科学 | 3385篇 |
药学 | 12004篇 |
中国医学 | 711篇 |
肿瘤学 | 19809篇 |
出版年
2023年 | 459篇 |
2022年 | 625篇 |
2021年 | 1553篇 |
2020年 | 930篇 |
2019年 | 1488篇 |
2018年 | 23373篇 |
2017年 | 18378篇 |
2016年 | 20611篇 |
2015年 | 2252篇 |
2014年 | 2691篇 |
2013年 | 3520篇 |
2012年 | 10829篇 |
2011年 | 24852篇 |
2010年 | 20777篇 |
2009年 | 13294篇 |
2008年 | 22725篇 |
2007年 | 24866篇 |
2006年 | 3615篇 |
2005年 | 5122篇 |
2004年 | 6054篇 |
2003年 | 6733篇 |
2002年 | 4734篇 |
2001年 | 603篇 |
2000年 | 644篇 |
1999年 | 503篇 |
1998年 | 666篇 |
1997年 | 538篇 |
1996年 | 379篇 |
1995年 | 408篇 |
1994年 | 356篇 |
1993年 | 284篇 |
1992年 | 179篇 |
1991年 | 230篇 |
1990年 | 252篇 |
1989年 | 190篇 |
1988年 | 168篇 |
1987年 | 128篇 |
1986年 | 127篇 |
1985年 | 143篇 |
1984年 | 146篇 |
1983年 | 141篇 |
1982年 | 157篇 |
1981年 | 168篇 |
1980年 | 151篇 |
1979年 | 75篇 |
1978年 | 73篇 |
1977年 | 69篇 |
1976年 | 75篇 |
1974年 | 81篇 |
1938年 | 64篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
Timothy Threlfall Neil Kent Peter Garcia-Webb Elizabeth Byrnes Paul Psaila-Savona 《Australian and New Zealand journal of public health》1993,17(4):379-381
Abstract: This study reports on an analysis of the lead concentrations in 123 venous blood samples collected from Perth children aged between two months and 17 years attending Princess Margaret Hospital. The overall geometric mean was 6.9 μg lead per 100 ml whole blood, with 95 per cent of results lying between 3.2 and 14.8 μg/100 ml. Among children under five years of age, those aged between 18 months and two years had the highest geometric mean blood lead (11.1 μg/100 ml). There were no consistent associations between geometric mean blood lead and area of residence, age group or sex. In this sample of Perth children, the mean blood lead concentration was lower than those reported in other studies. Less than 0.1 per cent of children of the age range studied would have been expected to have lead levels exceeding the NHMRC ‘level of concern’ (25 μg/100 ml) current at the time of the study. However, the recent adoption of goal of less than 10 μg/100 ml could mean that lead levels in up to 21 per cent of Perth children would now be regarded as excessive. 相似文献
72.
Irwin L. Flink 《Brain structure & function》2002,205(3):235-244
73.
74.
75.
Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. 总被引:13,自引:0,他引:13
Elliott J Mufson Shuang Y Ma John Dills Elizabeth J Cochran Sue Leurgans Joanne Wuu David A Bennett Syed Jaffar Michelle L Gilmor Alan I Levey Jeffrey H Kordower 《The Journal of comparative neurology》2002,443(2):136-153
The long-held belief that degeneration of the cholinergic basal forebrain was central to Alzheimer's disease (AD) pathogenesis and occurred early in the disease process has been questioned recently. In this regard, changes in some cholinergic basal forebrain (CBF) markers (e.g. the high affinity trkA receptor) but not others (e.g., cortical choline acetyltransferase [ChAT] activity, the number of ChAT and vesicular acetylcholine transporter-immunoreactive neurons) suggest specific phenotypic changes, but not frank neuronal degeneration, early in the disease process. The present study examined the expression of the low affinity p75 neurotrophin receptor (p75(NTR)), an excellent marker of CBF neurons, in postmortem tissue derived from clinically well-characterized individuals who have been classified as having no cognitive impairment (NCI), mild cognitive impairment (MCI), and mild AD. Relative to NCI individuals, a significant and similar reduction in the number of nucleus basalis p75(NTR)-immunoreactive neurons was seen in individuals with MCI (38%) and mild AD (43%). The number of p75(NTR)-immunoreactive nucleus basalis neurons was significantly correlated with performance on the Mini-Mental State Exam, a Global Cognitive Test score, as well as some individual tests of working memory and attention. These data, together with previous reports, support the concept that phenotypic changes, but not frank neuronal degeneration, occur early in cognitive decline. Although there was no difference in p75(NTR) CBF cell reduction between MCI and AD, it remains to be determined whether these findings lend support to the hypothesis that MCI is a prodromal stage of AD. 相似文献
76.
77.
Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. 总被引:5,自引:0,他引:5
William D Leslie Colleen Metge Elizabeth A Salamon C Kin Yuen 《Journal of clinical densitometry》2002,5(2):117-130
The ease of measurement and the quantitative nature of bone mineral densitometry (BMD) is clinically appealing. Despite BMD's proven capability to stratify fracture risk, data indicate that clinical risk factors provide complementary information on fracture susceptibility that is independent of BMD. Methods to quantify fracture risk using both clinical and BMD variables would have great appeal for clinical decision-making. We describe a procedure for quantifying hip fracture risk (5-yr and remaining lifetime) based on (1) the individual's age alone (base model, assuming average clinical risk factors and bone density), (2) incorporation of multiple patient-specific clinical risk factor data in the base model, and (3) incorporation of both patient-specific clinical risk factor data and BMD results. 相似文献
78.
79.
N Gilmore L Cherian W R Klemm 《Progress in neuro-psychopharmacology & biological psychiatry》1991,15(1):91-104
1. This laboratory has previously reported that pretreatment with ganglioside, or even with its constituent, sialic acid (SA), can attenuate certain intoxicating effects of ethanol. It was important to see if these findings could be replicated, particularly by using other measures of ethanol effects. Herein we report that pretreatment with either gangliosides or SA attenuated ethanol-induced decrements in locomotion, nose-poke exploration, and anxiety, but not body temperature. 2. An ethanol dose of 4 gm/kg caused a temperature drop of about 3 degrees C, which was unaffected by any pretreatment. The onset to sleep, however, was delayed an average of 18 or 36 secs in mice pretreated with ganglioside or SA, respectively. Ethanol-only (4 gm/kg) depressed mean cumulative locomotor activity to 31% of normal, whereas the depression was 83% of normal with beef brain ganglioside pretreatment. At 2 gm/kg ethanol alone decreased nose poking in a hole-board test to 29% of normal, but the depression was only 55-63% of normal with SA or ganglioside pretreatment. In a staircase climbing anxiety test, this dose of ethanol had no effect by itself, but both ganglioside and SA pre-treatment increased climbing by 22%. Ethanol did depress rearing to only 11% of normal, whereas rearing was 51 and 99% of normal with SA and ganglioside pretreatment, respectively. In a dark-preference test, ethanol-only caused mice to spend 64% of the time in the light, compared to 31% for controls. Time in the light was only 39 and 46% with ganglioside and SA pretreatment, respectively. 3. Blood levels of ethanol were not significantly affected by pretreatment. 4. When given alone, gangliosides significantly stimulated locomotion and staircase climbing. SA significantly decreased rearing in the staircase test. Both gangliosides and SA tended to increase nose poking, number of crossings in the dark-preference test, and time in a lighted compartment. Thus, it is possible that some of the attenuation of intoxication is attributable to non-specific stimulant properties of gangliosides and SA. 相似文献
80.